Act or Defer: Error-Controlled Decision Policies for Medical Foundation Models
Jin, Y.; Moon, I.; Zitnik, M.
Show abstract
Clinical deployment of foundation models requires decision policies that operate under explicit error budgets, such as a cap on false-positive clinical calls. Strong average accuracy alone does not guarantee safety: errors can concentrate among patients selected for action, leading to harm and inefficient use of healthcare resources. Here we introduce SO_SCPLOWTRATC_SCPLOWCP, a stratified conformal framework that turns foundation model predictions into decision-ready outputs through error-controlled selection and calibrated deferral. SO_SCPLOWTRATC_SCPLOWCP first selects a subset of patients for immediate clinical action while controlling the false discovery rate at a user-specified level. For the remaining patients, it returns prediction sets that achieve target coverage conditional on deferral, supporting confirmatory testing or expert review. When clinical guidelines define relationships among disease states, SO_SCPLOWTRATC_SCPLOWCP incorporates a utility graph to produce clinically coherent prediction sets without sacrificing coverage guarantees. We evaluate SO_SCPLOWTRATC_SCPLOWCP in ophthalmology and neuro-oncology across diagnosis, biomarker prediction, and time-to-event prognosis. Across tasks, SO_SCPLOWTRATC_SCPLOWCP controls the false discovery rate among selected patients and provides valid, selection-conditional coverage for deferred patients. In neuro-oncology, it enables H&E-based diagnosis under a fixed error budget, reducing reliance on reflex molecular assays and lowering laboratory cost and turnaround time. SO_SCPLOWTRATC_SCPLOWCP establishes error-controlled decision policies for safe deployment of medical foundation models.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Zero-shot drug repurposing with geometric deep learning and clinician centered design 94%
- Machine learning guided signal enrichment for ultrasensitive plasma tumor burden monitoring 93%
- Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and SARS-CoV-2 variants 92%
Similar papers in this journal
- Learning interpretable cellular and gene signature embeddings from single-cell transcriptomic data 95%
- scDisInFact: disentangled learning for integration and prediction of multi-batch multi-condition single-cell RNA-sequencing data 94%
- scPRINT: pre-training on 50 million cells allows robust gene network predictions 94%
Similar papers in this journal
Similar papers in this journal
- Cell states and neighborhoods in distinct clinical stages of primary and metastatic esophageal adenocarcinoma 92%
- Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma 91%
- Systematic annotation of orphan RNAs reveals blood-accessible molecular barcodes of cancer identity and cancer-emergent oncogenic drivers 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.